Target Name: MIR3085
NCBI ID: G113839520
Review Report on MIR3085 Target / Biomarker Content of Review Report on MIR3085 Target / Biomarker
MIR3085
Other Name(s): microRNA 3085 | MicroRNA 3085 | hsa-miR-3085-5p | hsa-miR-3085-3p | hsa-mir-3085

MicroRNA 3085: A Potential Drug Target Or Biomarker

MicroRNA (miRNA) 3085 is a non-coding RNA molecule that plays a crucial role in various biological processes. It is a part of the 3085 cluster of miRNAs, which are known for their involvement in various cellular processes such as cell growth, differentiation, and apoptosis. One of the most significant functions of these miRNAs is their ability to regulate gene expression, thereby influencing the development and progression of diseases.

MIR3085 is a highly conserved miRNA that is found in various organisms, including humans. It is expressed in a variety of tissues, including the brain, heart, liver, and muscle. The expression level of MIR3085 varies depending on the cell type and the environmental conditions. MIR3085 is known to be involved in the regulation of cellular processes such as cell adhesion, migration, and the cell cycle.

One of the most significant functions of MIR3085 is its ability to regulate the expression of target genes. It interacts with various protein coding genes, often by binding to their mRNAs. This interaction between MIR3085 and target genes is critical for the regulation of cellular processes. MIR3085 can also inhibit the activity of some viruses, such as HIV, by interfering with their replication.

Another function of MIR3085 is its role in the regulation of cellular apoptosis. Apoptosis is a natural process that is essential for the elimination of damaged or dysfunctional cells. MIR3085 has been shown to play a role in the regulation of apoptosis by interacting with the protein Bcl-2. Bcl-2 is a protein that can prevent apoptosis, and MIR3085 has been shown to inhibit its activity by binding to it. This inhibition of Bcl-2 activity can lead to the rescue of damaged or dysfunctional cells, which can have implications for the treatment of various diseases.

MIR3085 is also involved in the regulation of cellular signaling pathways. It has been shown to interact with various signaling pathways, including the TGF-β pathway. TGF-β is a signaling pathway that plays a role in the regulation of cellular processes such as cell growth, differentiation, and apoptosis. MIR3085 has been shown to be involved in the regulation of TGF-β signaling by interacting with the protein Smad4. This interaction between MIR3085 and Smad4 can lead to the regulation of cellular processes, including the regulation of cell adhesion and the regulation of the cell cycle.

MIR3085 is also involved in the regulation of cellular transport processes. It has been shown to interact with various transport proteins, including the protein Trans-Actinin-4 (T-ACTN4). T-ACTN4 is a protein that is involved in the regulation of cellular transport processes, and MIR3085 has been shown to be involved in its regulation. This interaction between MIR3085 and T-ACTN4 can lead to the regulation of cellular transport processes, including the regulation of the movement of cells.

In conclusion, MIR3085 is a microRNA that plays a crucial role in various cellular processes. Its interaction with various protein coding genes, as well as its involvement in the regulation of cellular apoptosis, signaling pathways, and transport processes, make it an attractive drug target or biomarker. Further research is needed to fully understand the role of MIR3085 in cellular processes and its potential as a drug or biomarker.

Protein Name: MicroRNA 3085

The "MIR3085 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3085 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185